Investigative Site

Doral, Florida 33178

0 studies enrolling now · 3 studies all time

What they study most

Covid19, Parkinson Disease

Studies at this site

• A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease — Stopped early
• Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19. — Stopped early
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed